GlassScriptPhysician profile
Lily L Lee
NPI 1255406880
$2,895.79
in general payments reported to CMS, 2019-2025
30 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $210 · 2021: $759 · 2022: $557 · 2023: $543 · 2024: $187 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.57 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $335.14 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $303.33 | 2022-2025 | |
| Allergan, INC. | $297.60 | 2019-2021 | |
| Therapeuticsmd, INC. | $174.32 | 2019-2022 | |
| Exeltis, USA INC. | $165.66 | 2019-2024 | Slynd |
| Myriad Women'S Health, INC. | $90.29 | 2023 | Myrisk |
| Millicent US INC | $78.35 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Mylan Pharmaceuticals INC. | $72.22 | 2021-2022 | |
| Astellas Pharma US INC | $72.07 | 2023-2024 | Veozah |
| Evofem Biosciences, INC. | $70.18 | 2021-2022 | |
| Hologic Sales and Service, LLC | $61.59 | 2020-2023 | Acessa Provu System |
| Sumitomo Pharma America, INC. | $48.87 | 2023 | Myfembree |
| Organon LLC | $48.05 | 2022-2024 | |
| Scynexis, INC. | $35.53 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.45 | 2023 | |
| 180 Medical, INC. | $24.97 | 2023 | |
| Shield Therapeutics INC | $23.51 | 2023 | Accrufer |
| Lupin INC. | $22.66 | 2020 | |
| Coopersurgical, INC. | $22.45 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.00 | 2019 | |
| Amag Pharmaceuticals, INC. | $21.41 | 2019 | |
| Aspira Women'S Health INC | $19.99 | 2024 | Ova1 |
| Novo Nordisk INC | $18.83 | 2024 | Saxenda, Wegovy |
| Exact Sciences Corporation | $17.79 | 2025 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $16.46 | 2022 | |
| Channel Medsystems, INC. | $15.88 | 2022 | |
| Currax Pharmaceuticals LLC | $15.85 | 2024 | Contrave |
| Baxter Healthcare | $15.39 | 2022 | |
| Mission Pharmacal Company | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lily Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.